Barclays
CBPO

Barclays’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Barclays’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,100
Closed -$192K – 7581
2019
Q1 		$192K Buy
+2,100
New +$172K ﹤0.01% 4862
2018
Q4 		– Sell
-100
Closed -$8K – 7776
2018
Q3 		$8K Buy
+100
New +$9.32K ﹤0.01% 6714

Barclays's CBPO Position: Q2 2021 in Review

Barclays sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 9,892 shares — an estimated $1.17M sold.

Barclays first reported a position in CBPO in Q4 2015 and held it in 21 quarters. The position peaked at $1.61M in Q3 2020. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

  • Barclays reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
  • Barclays sold 9,892 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $1.17M.
  • Barclays first reported a position in China Biologic Products Holdings, Inc. in Q4 2015 and held it in 21 quarters.
  • Barclays's China Biologic Products Holdings, Inc. position peaked at $1.61M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.